VBIV
VBI Vaccines Inc
NASDAQ: VBIV · HEALTHCARE · BIOTECHNOLOGY
$0.07
+0.00% today
Updated 2026-06-04
Market cap
$1.87M
P/E ratio
—
P/S ratio
0.20x
EPS (TTM)
$-3.54
Dividend yield
—
52W range
$0 – $0
Volume
—
VBI Vaccines Inc (VBIV) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-69.0%
Last 4 quarters
Revenue YoY growth
+150.3%
Most recent quarter
EPS YoY growth
+77.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-03-31 | $-0.53 | $-0.73 | -37.7% | $1.21M | +150.3% |
| 2023-12-31 | $-0.22 | $-0.01 | +95.5% | $853000.00 | +191.1% |
| 2023-09-30 | $-0.14 | $-1.01 | -621.4% | $6.62M | +1989.6% |
| 2023-06-30 | $-2.16 | $-5.05 | -133.8% | $720000.00 | +108.1% |
| 2023-03-31 | $-1.25 | $-3.22 | -157.6% | $485000.00 | +284.9% |
| 2022-12-31 | $-0.07 | $-0.08 | -14.3% | $293000.00 | +261.7% |
| 2022-09-30 | $-0.08 | $-0.09 | -12.5% | $317000.00 | +196.3% |
| 2022-06-30 | $-0.07 | $-0.18 | -157.1% | $346000.00 | +143.7% |
| 2022-03-31 | $-0.08 | $-0.08 | +0.0% | $126000.00 | — |
| 2021-12-31 | $-0.07 | $-0.07 | +0.0% | $81000.00 | — |
| 2021-09-30 | $-0.07 | $-0.06 | +14.3% | $107000.00 | — |
| 2021-06-30 | $-0.06 | $-0.07 | -16.7% | $142000.00 | — |
Frequently asked questions
Has VBI Vaccines Inc beaten earnings estimates?
VBI Vaccines Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, averaging a -69.0% surprise over the last 4. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.
What is VBI Vaccines Inc's revenue growth rate?
VBI Vaccines Inc reported year-over-year revenue growth of +150.3% in its most recent quarter, with EPS up +77.3%. Reading revenue growth alongside margins shows whether that growth is translating into profit.